Sfoglia per Autore
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts
2014-01-01 Passamonti, Francesco; Maffioli, M.; Cervantes, F.; Vannucchi, A. M.; Morra, E.; Barbui, T.; Caramazza, D.; Pieri, L.; Rumi, E.; Gisslinger, H.; Knoops, L.; Kiladjian, J. J.; Mora, B.; Hollaender, N.; Pascutto, C.; Harrison, C.; Cazzola, M.
Looking for CALR mutations in familial myeloproliferative neoplasms
2014-01-01 Maffioli, M.; Genoni, A.; Caramazza, D.; Mora, B.; Bussini, A.; Merli, M.; Giorgino, T.; Casalone, R.; Passamonti, Francesco
It is time to change thrombosis risk assessment for PV and ET?
2014-01-01 Passamonti, Francesco; Domenica, Caramazza; Mora, Barbara; Rosario, Casalone; Margherita, Maffioli
Prognostication in myelofi-brosis
2015-01-01 Passamonti, Francesco; Caramazza, D.; Mora, B.; Maffioli, M.
New molecular genetics in the diagnosis and treatment of myeloproliferative neoplasms
2016-01-01 Passamonti, Francesco; Mora, B.; Maffioli, M.
Therapy of polycythemia vera: Is it time to change?
2017-01-01 Passamonti, Francesco; Maffioli, Margherita; Mora, Barbara
Driver mutations' effect in secondary myelofibrosis: An international multicenter study based on 781 patients
2017-01-01 Passamonti, Francesco; Mora, B.; Giorgino, T.; Guglielmelli, P.; Cazzola, M.; Maffioli, M.; Rambaldi, A.; Caramella, M.; Komrokji, R.; Gotlib, J.; Kiladjian, J. J.; Cervantes, F.; Devos, T.; Palandri, F.; De Stefano, V.; Ruggeri, M.; Silver, R.; Benevolo, G.; Albano, F.; Caramazza, D.; Rumi, E.; Merli, M.; Pietra, D.; Casalone, R.; Barbui, T.; Pieri, L.; Vannucchi, A. M.
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion
2017-01-01 Pessina, Chiara; Basilico, Claudia; Genoni, Angelo; Meroni, Emanuela; Elli, Lorenzo; Granata, Paola; Righi, Rossana; Pallotti, Francesco; Mora, Barbara; Ferrario, Andrea; Passamonti, Francesco; Casalone, Rosario
Polycythemia vera: From new, modified diagnostic criteria to new therapeutic approaches
2017-01-01 Maffioli, Margherita; Mora, Barbara; Passamonti, Francesco
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients
2017-01-01 Ruberti, S; Bianchi, E; Guglielmelli, P; Rontauroli, S; Barbieri, G; Tavernari, L; Fanelli, T; Norfo, R; Pennucci, V; Fattori, G. Corbizi; Mannarelli, C; Bartalucci, N; Mora, B; Elli, L; Avanzini, M. A; Rossi, C; Salmoiraghi, S; Zini, R; Salati, S; Prudente, Z; Rosti, V; Passamonti, F; Rambaldi, A; Ferrari, S; Tagliafico, E; Vannucchi, A. M; Manfredini, R.
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
2017-01-01 Passamonti, F; Giorgino, T; Mora, B; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, J. J; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, R. T; Benevolo, G; Albano, F; Caramazza, D; Merli, M; Pietra, D; Casalone, R; Rotunno, G; Barbui, T; Cazzola, M; Vannucchi, A. M.
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC project
2018-01-01 Mora, Barbara; Giorgino, Toni; Guglielmelli, Paola; Rumi, Elisa; Maffioli, Margherita; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami; Gotlib, Jason; Kiladjian, Jean Jacques; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri, Marco; Silver, Richard T.; Benevolo, Giulia; Albano, Francesco; Cavalloni, Chiara; Barraco, Daniela; Merli, Michele; Pietra, Daniela; Casalone, Rosario; Barbui, Tiziano; Rotunno, Giada; Cazzola, Mario; Vannucchi, Alessandro Maria; Passamonti, Francesco
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia
2018-01-01 Mora, Barbara; Giorgino, Toni; Guglielmelli, Paola; Rumi, Elisa; Maffioli, Margherita; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami; Gotlib, Jason; Kiladjian, Jean Jacques; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri, Marco; Silver, Richard T.; Benevolo, Giulia; Albano, Francesco; Cavalloni, Chiara; Barraco, Daniela; Pietra, Daniela; Barbui, Tiziano; Rotunno, Giada; Vannucchi, Alessandro Maria; Passamonti, Francesco
Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis
2018-01-01 Passamonti, Francesco; Mora, Barbara; Barraco, Daniela; Maffioli, Margherita
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project
2018-01-01 Barraco, Daniela; Mora, Barbara; Guglielmelli, Paola; Rumi, Elisa; Maffioli, Margherita; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami; Gotlib, Jason; Kiladjian, Jean Jacques; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri, Marco; Silver, Richard T.; Benevolo, Giulia; Albano, Francesco; Merli, Michele; Pietra, Daniela; Barbui, Tiziano; Rotunno, Giada; Cazzola, Mario; Giorgino, Toni; Vannucchi, Alessandro Maria; Passamonti, Francesco
Validation and further potentialities of the novel AWM score for progression risk stratification in patients with asymptomatic Waldenström macroglobulinemia
2019-01-01 Merli, M.; Bianchi, B.; Bertu, L.; Ferrario, A.; Mora, B.; Furlan, D.; Uccella, S.; Sessa, F.; Passamonti, F.
Developments in diagnosis and treatment of essential thrombocythemia
2019-01-01 Mora, Barbara; Passamonti, Francesco
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
2019-01-01 Mora, B.; Rumi, E.; Guglielmelli, P.; Barraco, D.; Maffioli, M.; Rambaldi, A.; Caramella, M.; Komrokji, R.; Gotlib, J.; Kiladjian, J. J.; Cervantes, F.; Devos, T.; Palandri, F.; Stefano, V. D.; Ruggeri, M.; Silver, R. T.; Benevolo, G.; Albano, F.; Cavalloni, C.; Pietra, D.; Barbui, T.; Rotunno, G.; Cazzola, M.; Vannucchi, A. M.; Giorgino, T.; Passamonti, F.
Second primary malignancies in ruxolitinib-treated myelofibrosis: Real-world evidence from 219 consecutive patients
2019-01-01 Maffioli, M.; Giorgino, T.; Mora, B.; Iurlo, A.; Elli, E.; Finazzi, M. C.; Caramella, M.; Rumi, E.; Carraro, M. C.; Polverelli, N.; D'Adda, M.; Malato, S.; Rossi, M.; Molteni, A.; Vismara, A.; Sissa, C.; Spina, F.; Anghilieri, M.; Cattaneo, D.; Renso, R.; Bellini, M.; Pioltelli, M. L.; Cavalloni, C.; Barraco, D.; Accetta, R.; Bertu, L.; Porta, M. G. D.; Passamonti, F.
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
2020-01-01 Debureaux, Pierre-Edouard; Cassinat, Bruno; Soret-Dulphy, Juliette; Mora, Barbara; Verger, Emmanuelle; Maslah, Nabih; Plessier, Aurelie; Rautou, Pierre-Emmanuel; Ollivier-Hourman, Isabelle; De Ledinghen, Victor; Goria, Odile; Bureau, Christophe; Siracusa, Claudia; Valla, Dominique; Giraudier, Stephane; Passamonti, Francesco; Kiladjian, Jean-Jacques
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts | 1-gen-2014 | Passamonti, Francesco; Maffioli, M.; Cervantes, F.; Vannucchi, A. M.; Morra, E.; Barbui, T.; Caramazza, D.; Pieri, L.; Rumi, E.; Gisslinger, H.; Knoops, L.; Kiladjian, J. J.; Mora, B.; Hollaender, N.; Pascutto, C.; Harrison, C.; Cazzola, M. | |
| Looking for CALR mutations in familial myeloproliferative neoplasms | 1-gen-2014 | Maffioli, M.; Genoni, A.; Caramazza, D.; Mora, B.; Bussini, A.; Merli, M.; Giorgino, T.; Casalone, R.; Passamonti, Francesco | |
| It is time to change thrombosis risk assessment for PV and ET? | 1-gen-2014 | Passamonti, Francesco; Domenica, Caramazza; Mora, Barbara; Rosario, Casalone; Margherita, Maffioli | |
| Prognostication in myelofi-brosis | 1-gen-2015 | Passamonti, Francesco; Caramazza, D.; Mora, B.; Maffioli, M. | |
| New molecular genetics in the diagnosis and treatment of myeloproliferative neoplasms | 1-gen-2016 | Passamonti, Francesco; Mora, B.; Maffioli, M. | |
| Therapy of polycythemia vera: Is it time to change? | 1-gen-2017 | Passamonti, Francesco; Maffioli, Margherita; Mora, Barbara | |
| Driver mutations' effect in secondary myelofibrosis: An international multicenter study based on 781 patients | 1-gen-2017 | Passamonti, Francesco; Mora, B.; Giorgino, T.; Guglielmelli, P.; Cazzola, M.; Maffioli, M.; Rambaldi, A.; Caramella, M.; Komrokji, R.; Gotlib, J.; Kiladjian, J. J.; Cervantes, F.; Devos, T.; Palandri, F.; De Stefano, V.; Ruggeri, M.; Silver, R.; Benevolo, G.; Albano, F.; Caramazza, D.; Rumi, E.; Merli, M.; Pietra, D.; Casalone, R.; Barbui, T.; Pieri, L.; Vannucchi, A. M. | |
| A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion | 1-gen-2017 | Pessina, Chiara; Basilico, Claudia; Genoni, Angelo; Meroni, Emanuela; Elli, Lorenzo; Granata, Paola; Righi, Rossana; Pallotti, Francesco; Mora, Barbara; Ferrario, Andrea; Passamonti, Francesco; Casalone, Rosario | |
| Polycythemia vera: From new, modified diagnostic criteria to new therapeutic approaches | 1-gen-2017 | Maffioli, Margherita; Mora, Barbara; Passamonti, Francesco | |
| Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients | 1-gen-2017 | Ruberti, S; Bianchi, E; Guglielmelli, P; Rontauroli, S; Barbieri, G; Tavernari, L; Fanelli, T; Norfo, R; Pennucci, V; Fattori, G. Corbizi; Mannarelli, C; Bartalucci, N; Mora, B; Elli, L; Avanzini, M. A; Rossi, C; Salmoiraghi, S; Zini, R; Salati, S; Prudente, Z; Rosti, V; Passamonti, F; Rambaldi, A; Ferrari, S; Tagliafico, E; Vannucchi, A. M; Manfredini, R. | |
| A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis | 1-gen-2017 | Passamonti, F; Giorgino, T; Mora, B; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, J. J; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, R. T; Benevolo, G; Albano, F; Caramazza, D; Merli, M; Pietra, D; Casalone, R; Rotunno, G; Barbui, T; Cazzola, M; Vannucchi, A. M. | |
| Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC project | 1-gen-2018 | Mora, Barbara; Giorgino, Toni; Guglielmelli, Paola; Rumi, Elisa; Maffioli, Margherita; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami; Gotlib, Jason; Kiladjian, Jean Jacques; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri, Marco; Silver, Richard T.; Benevolo, Giulia; Albano, Francesco; Cavalloni, Chiara; Barraco, Daniela; Merli, Michele; Pietra, Daniela; Casalone, Rosario; Barbui, Tiziano; Rotunno, Giada; Cazzola, Mario; Vannucchi, Alessandro Maria; Passamonti, Francesco | |
| Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia | 1-gen-2018 | Mora, Barbara; Giorgino, Toni; Guglielmelli, Paola; Rumi, Elisa; Maffioli, Margherita; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami; Gotlib, Jason; Kiladjian, Jean Jacques; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri, Marco; Silver, Richard T.; Benevolo, Giulia; Albano, Francesco; Cavalloni, Chiara; Barraco, Daniela; Pietra, Daniela; Barbui, Tiziano; Rotunno, Giada; Vannucchi, Alessandro Maria; Passamonti, Francesco | |
| Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis | 1-gen-2018 | Passamonti, Francesco; Mora, Barbara; Barraco, Daniela; Maffioli, Margherita | |
| Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project | 1-gen-2018 | Barraco, Daniela; Mora, Barbara; Guglielmelli, Paola; Rumi, Elisa; Maffioli, Margherita; Rambaldi, Alessandro; Caramella, Marianna; Komrokji, Rami; Gotlib, Jason; Kiladjian, Jean Jacques; Cervantes, Francisco; Devos, Timothy; Palandri, Francesca; De Stefano, Valerio; Ruggeri, Marco; Silver, Richard T.; Benevolo, Giulia; Albano, Francesco; Merli, Michele; Pietra, Daniela; Barbui, Tiziano; Rotunno, Giada; Cazzola, Mario; Giorgino, Toni; Vannucchi, Alessandro Maria; Passamonti, Francesco | |
| Validation and further potentialities of the novel AWM score for progression risk stratification in patients with asymptomatic Waldenström macroglobulinemia | 1-gen-2019 | Merli, M.; Bianchi, B.; Bertu, L.; Ferrario, A.; Mora, B.; Furlan, D.; Uccella, S.; Sessa, F.; Passamonti, F. | |
| Developments in diagnosis and treatment of essential thrombocythemia | 1-gen-2019 | Mora, Barbara; Passamonti, Francesco | |
| Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients | 1-gen-2019 | Mora, B.; Rumi, E.; Guglielmelli, P.; Barraco, D.; Maffioli, M.; Rambaldi, A.; Caramella, M.; Komrokji, R.; Gotlib, J.; Kiladjian, J. J.; Cervantes, F.; Devos, T.; Palandri, F.; Stefano, V. D.; Ruggeri, M.; Silver, R. T.; Benevolo, G.; Albano, F.; Cavalloni, C.; Pietra, D.; Barbui, T.; Rotunno, G.; Cazzola, M.; Vannucchi, A. M.; Giorgino, T.; Passamonti, F. | |
| Second primary malignancies in ruxolitinib-treated myelofibrosis: Real-world evidence from 219 consecutive patients | 1-gen-2019 | Maffioli, M.; Giorgino, T.; Mora, B.; Iurlo, A.; Elli, E.; Finazzi, M. C.; Caramella, M.; Rumi, E.; Carraro, M. C.; Polverelli, N.; D'Adda, M.; Malato, S.; Rossi, M.; Molteni, A.; Vismara, A.; Sissa, C.; Spina, F.; Anghilieri, M.; Cattaneo, D.; Renso, R.; Bellini, M.; Pioltelli, M. L.; Cavalloni, C.; Barraco, D.; Accetta, R.; Bertu, L.; Porta, M. G. D.; Passamonti, F. | |
| Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses | 1-gen-2020 | Debureaux, Pierre-Edouard; Cassinat, Bruno; Soret-Dulphy, Juliette; Mora, Barbara; Verger, Emmanuelle; Maslah, Nabih; Plessier, Aurelie; Rautou, Pierre-Emmanuel; Ollivier-Hourman, Isabelle; De Ledinghen, Victor; Goria, Odile; Bureau, Christophe; Siracusa, Claudia; Valla, Dominique; Giraudier, Stephane; Passamonti, Francesco; Kiladjian, Jean-Jacques |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile